Cargando…
Genome-scale mutational signatures of aflatoxin in cells, mice, and human tumors
Aflatoxin B1 (AFB1) is a mutagen and IARC (International Agency for Research on Cancer) Group 1 carcinogen that causes hepatocellular carcinoma (HCC). Here, we present the first whole-genome data on the mutational signatures of AFB1 exposure from a total of >40,000 mutations in four experimental...
Autores principales: | Huang, Mi Ni, Yu, Willie, Teoh, Wei Wei, Ardin, Maude, Jusakul, Apinya, Ng, Alvin Wei Tian, Boot, Arnoud, Abedi-Ardekani, Behnoush, Villar, Stephanie, Myint, Swe Swe, Othman, Rashidah, Poon, Song Ling, Heguy, Adriana, Olivier, Magali, Hollstein, Monica, Tan, Patrick, Teh, Bin Tean, Sabapathy, Kanaga, Zavadil, Jiri, Rozen, Steven G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5580708/ https://www.ncbi.nlm.nih.gov/pubmed/28739859 http://dx.doi.org/10.1101/gr.220038.116 |
Ejemplares similares
-
First somatic mutation of E2F1 in a critical DNA binding residue discovered in well-differentiated papillary mesothelioma of the peritoneum
por: Yu, Willie, et al.
Publicado: (2011) -
Base changes in tumour DNA have the power to reveal the causes and evolution of cancer
por: Hollstein, M, et al.
Publicado: (2017) -
Critical analysis of science textbooks: evaluating instructional effectiveness
por: Khine, Myint Swe
Publicado: (2013) -
Mutation signatures implicate aristolochic acid in bladder cancer development
por: Poon, Song Ling, et al.
Publicado: (2015) -
Longitudinal metabolic imaging of hepatocellular carcinoma in transgenic mouse models identifies acylcarnitine as a potential biomarker for early detection
por: Yaligar, Jadegoud, et al.
Publicado: (2016)